LSTM Home > LSTM Research > LSTM Online Archive

Essential medicines and access to insulin

Gill, Geoff, Yudkin, John S, Tesfaye, Solomon, de Courten, Maximilian, Gale, Edwin, Motala, Ayesha, Ramaiya, Kaushik, Unwin, Nigel and Wild, Sarah (2017) 'Essential medicines and access to insulin'. Lancet Diabetes and Endocrinology, Vol 5, Issue 5, pp. 324-325.

Lancet_Essential medicines_15_3_17.pdf - Published Version

Download (37kB) | Preview


We fully support the views expressed in The Lancet Diabetes & Endocrinology's Editorial about ensuring affordable access to insulin and the proposal to add analogue insulin to the WHO Essential Medicines list. The International Insulin Foundation in its 2011 position statement called for “the universal access for persons with type 1 diabetes to life-saving and life-preserving insulin”. In 2012, we launched the 100 Campaign, which sets the target of 100% affordability and 100% availability of insulin worldwide by the year 2022 (100 years after the introduction of insulin for people with diabetes).

Item Type: Article
Additional Information: Correspondence.
Subjects: W General Medicine. Health Professions > W 74 Medical economics. Health care costs
WK Endocrine System > WK 810 Diabetes mellitus
WK Endocrine System > WK 820 Insulin and its modifications
Faculty: Department: Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):
SWORD Depositor: JISC Pubrouter
Depositing User: Stacy Murtagh
Date Deposited: 13 Apr 2017 11:56
Last Modified: 18 Sep 2017 01:02


View details

Actions (login required)

Edit Item Edit Item